
ChromaCode
Multiplexing the way it should be
Carlsbad, United States · Founded 2015 · $90.5M raised
- Headquarters
- Carlsbad, California
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- chromacode.com
- Total Funding
- $90.5M
- Last Round
- $38.0M Corporate RoundFeb 2023
- Rounds
- 5
About
ChromaCode is a molecular diagnostics company that leverages patented mathematical methods and algorithmic enhancements to enrich signal processing from popular life science instrumentation. The company's High-Definition PCR (HDPCR) multiplexing platform enables transformative genomic solutions for oncology, minimal residual disease testing, and disease monitoring. ChromaCode's instrument-agnostic platform pairs proprietary innovations in chemistry and cloud-based software to deliver unprecedented multiplexing, with pedigree from Illumina, Google X, Luminex, and Caltech.
Summary
ChromaCode is a Bioinformatics company based in Carlsbad, United States, founded in 2015. It has raised $90.5M in total across 5 rounds, most recently a $38.0M Corporate Round round in Feb 2023. Investors include Adjuvant Capital and Domain Associates.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2023
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Cloud platform for omics data analysis and collaboration, serving biopharma and research teams to...
Big data platform for centralized management and processing of next-generation sequencing genomic...